Renal architectural changes in Plasmodium berghei inoculated mice

Authors

  • Omoirri MA Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Akwa, Anambra State, Nigeria.
  • Madubogwu NU Department of Pharmacology and Toxicology, Chukwuemeka Odumegu University, Igbariam, Anambra State, Nigeria.
  • Iloh SE Department of Pharmacology and Toxicology, Chukwuemeka Odumegu University, Igbariam, Anambra State, Nigeria.
  • Adejumo SA Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
  • Ojiako CM Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.

DOI:

https://doi.org/10.30574/gscbps.2020.13.3.0409

Keywords:

Kidney, Malaria, P. berghei, Renal Histo-architecture

Abstract

Plasmodium falciparum (P. falciparum) is a specie of Plasmodium parasite responsible for the pathogenicity of malaria, a disease with several complications reported as the leading cause of over 1 million deaths worldwide. In this study, the effects of malaria on the kidney (Renal) histo-architecture was studied ex-vivo in albino mice rats. Twenty one (21) albino mice rats of between 30 – 35g weights were procured, acclimatized for two weeks in the animal unit of the Ambrose Alli University, Ekpoma, Edo State. They were then grouped into three (3) of seven (7) mice each, following which group I received standard rat diet and water ad libitum (control). Using the 2ml syringe, Groups II and III were inoculated with 0.2 ml of the malaria parasite Plasmodium berghei each intra-peritoneally. While group II mice were left untreated for 7 days, group III (infested) mice were administered with 5.7 mg/kg body weight of Coartem (an anti-malaria), morning and evening for 1 week. Following period of administration of substances, kidneys were harvested, rid of adherent tissues, and subjected through histological scrutiny to ascertain the changes in renal histo-morphology across groups. For each group, body weight changes were also noted within test duration and compared between groups with the one way analysis of variance. Where differences exist, the tukey (Post Hoc) test was used to ascertain the cause of the differences in body weight due to P. berghei.  From the result, a statistically significant decrease (p > 0.05) in body weight was observed in P. berghei infested mice (Groups II and II) compared with control (group I). Body weight however recovered in Group III mice treated with coartem, proving to have increased significantly (p < 0.05) compared to control group. Renal histo-architectural changes revealed glomerulosclerosis, interstitial oedema and congested vessels in group II mice compared to control. We recommend similar study in other tissues other than the kidney for reference purposes.

Metrics

Metrics Loading ...

References

Barsoum RS. Malarial acute renal failure. J Am Soc Nephrol. 2000; 11: 2147–2154.

Kute VB, Trivedi HL, Vanikar AV, Shah PR, Gumber MR, Patel HV. Plasmodium vivax malaria–associated acute kidney injury, India, 2010–2011. Emerg Infect Dis. 2012; 18: 842–845.

Saravu K, Rishikesh K, Parikh CR. Risk factors and outcomes stratified by severity of acute kidney injury in Malaria. 2014; 9:e90419.

Elsheikha HM, Sheashaa HA. Epidemiology, pathophysiology, management and outcome of renal dysfunction associated with plasmodia infection. Parasitol Res. 2007; 101: 1183–1190.

Susan LP, Indra N, Richard C. The phylogeny of rodent malaria parasites: Simultaneous analysis across three genomes;Infection, Genetics and Evolution. 2007; 7(1): 74-83.

Taub D, Hoffsommer RD, Slates HL, Wendler NL. 16β-Methyl cortical steroids". Journal of the American Chemical Society. 1958; 80(16): 44-35.

Thiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, Diallo I, Ba F, Ndiaye JL, Albertini A, Lee E, Jorgensen, P, Gaye O, Bell D. Major reduction in anti-malaria drug consumption in senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS One. 2011; 6: 4.

White NJ. Assessment of the pharmacodynamic properties of antimalaria drugs in vivo. Antimicrobial Agents and Chemotherapy. 1997; 41: 1413–1422.

Neena V, Sunita B, Sadhna M, Sukla B, Aditya P. Congenial malaria with a typical presentation: A case report from low transmission area in India. Malaria J. 2007; 6: 43-48.

Zucker JR, Campbell CC. Malaria. Principles of prevention and treatment. Infect. Dis. 1993; 7(3): 547-567.

Pascual A, Madamet M, Bertaux L, Amalvict R, Benoit N, Travers D. In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene. Malar J. 2013; 12: 431.

Attaran A, Barnes KI, Curtis C, d’Alessandro U, Fanello CI, Galinski MR. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet. 2004; 363(9404): 237-40.

Obianime AW, Aprioku JS. Mechanism of action of artemisinin on biochemical, hematological and reproductive parameters in male guinea pigs. Int J Pharmacol. 2011; 7: 84-95

Downloads

Published

2020-12-30

How to Cite

Omoirri MA, Madubogwu NU, Iloh SE, Adejumo SA, & Ojiako CM. (2020). Renal architectural changes in Plasmodium berghei inoculated mice. GSC Biological and Pharmaceutical Sciences, 13(3), 222–227. https://doi.org/10.30574/gscbps.2020.13.3.0409

Issue

Section

Original Article